Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP2757984B2 - Transdermal medication system - Google Patents
[go: Go Back, main page]

JP2757984B2 - Transdermal medication system - Google Patents

Transdermal medication system

Info

Publication number
JP2757984B2
JP2757984B2 JP61140238A JP14023886A JP2757984B2 JP 2757984 B2 JP2757984 B2 JP 2757984B2 JP 61140238 A JP61140238 A JP 61140238A JP 14023886 A JP14023886 A JP 14023886A JP 2757984 B2 JP2757984 B2 JP 2757984B2
Authority
JP
Japan
Prior art keywords
drug
medicine
transdermal administration
transdermal
medication system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61140238A
Other languages
Japanese (ja)
Other versions
JPS62298375A (en
Inventor
広 石橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Priority to JP61140238A priority Critical patent/JP2757984B2/en
Publication of JPS62298375A publication Critical patent/JPS62298375A/en
Application granted granted Critical
Publication of JP2757984B2 publication Critical patent/JP2757984B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Media Introduction/Drainage Providing Device (AREA)

Description

【発明の詳細な説明】 本発明は、経皮投薬を行なうシステムに関する。 針、カニューレによる薬液の体内投与は、経皮投薬に
おいて効果的な方法であるが、慢性疾患患者、高齢者、
衰弱患者に対して連続的に用いることができず、しかも
毎回受ける刺痛は、患者にとって耐えがたいものであ
る。 一方、経皮投薬手段であって、体内に薬物の導入経路
を埋入せずに、皮膚表面に薬物を配置し、電気力あるい
は浸透圧を利用して薬物を導入する方法が近時注目され
つつあるが、皮膚表面、特にバリヤー層の組織的解明が
未だ不充分である為、実用化には至っていない。 上記に鑑み本発明者らは鋭意研究の結果、皮膚組織表
面上に経皮投与システムを配置し、体温による膨張する
膨張体により薬物を押圧することにより、汗腺及び毛穴
を通じ、体内への薬液浸透が行なわれることを知見し、
本発明に到達したものである。 以下、本発明経皮投薬装置につき実施例を用いて詳細
に説明する。 第1図は本発明の一実施例を示す断面図であり、保持
体(1)の鍔部(6)の接着部(3)によって密閉され
た保持体内部空間は、薬物部(4)及び加圧体(2)が
充填されている。加圧体(2)はフロンガス等を充填し
た伸縮する球状体から成り、生体の体温等によって膨張
し、薬物部が皮膚組織(5)を押圧、薬物部(4)の薬
剤が皮膚に浸透する。図に示すごとく、例えばポリエチ
レン等により、1体部材として構成するのが製造の観点
から好ましい。接着剤3としては、例えばビニルエマル
ジョン系接着剤が好ましい。 以上詳述の如く本発明経皮投薬システムは、皮膚表面
に配置した薬物部を少量の力によって押圧することによ
り、投薬が行なわれることから、簡単な構成で安全にし
かも確実に経皮投薬が行なわれる等、効果を奏効するも
のである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a system for transdermal administration. Intravenous administration of a drug solution via a needle or cannula is an effective method for transdermal administration.
The stinging that cannot be used continuously for debilitated patients and is received every time is unbearable for patients. On the other hand, a method of transdermal administration, in which a drug is placed on the skin surface without implanting a drug introduction route in the body and the drug is introduced using electric force or osmotic pressure, has recently attracted attention. However, the systematic elucidation of the skin surface, especially the barrier layer, is still insufficient, so that it has not been put to practical use. In view of the above, the present inventors have conducted intensive studies and as a result, arranged a transdermal administration system on the surface of skin tissue, and pressed the drug with an inflating body that expanded due to body temperature, thereby penetrating the drug solution into the body through sweat glands and pores. Knowing that
The present invention has been reached. Hereinafter, the transdermal administration device of the present invention will be described in detail using examples. FIG. 1 is a cross-sectional view showing one embodiment of the present invention, wherein an inner space of a holder sealed by a bonding portion (3) of a flange portion (6) of the holder (1) includes a drug part (4) and a drug part (4). The pressure body (2) is filled. The pressurized body (2) is made of a spheroidal body filled with Freon gas or the like, expands due to the body temperature of the living body, etc., the drug part presses the skin tissue (5), and the drug in the drug part (4) penetrates the skin. . As shown in the figure, it is preferable from a manufacturing standpoint to constitute it as a one-piece member with, for example, polyethylene. As the adhesive 3, for example, a vinyl emulsion adhesive is preferable. As described in detail above, the transdermal drug delivery system of the present invention performs drug delivery by pressing the drug portion disposed on the skin surface with a small amount of force, so that transdermal drug delivery can be performed safely and reliably with a simple configuration. It has an effect such as being performed.

【図面の簡単な説明】 第1図は、本発明経皮投薬システムの一実施例を示す断
面図である。 (1)……保持体、 (2)……加圧体、 (3)……接着剤、 (4)……薬物部、 (5)……皮膚組織、 (6)……鍔部。
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a sectional view showing an embodiment of the transdermal administration system of the present invention. (1) ... holding body, (2) ... pressurized body, (3) ... adhesive, (4) ... drug part, (5) ... skin tissue, (6) ... brim part.

Claims (1)

(57)【特許請求の範囲】 1.薬剤、該薬剤を保持する薬剤保持体、及び前記薬剤
保持体内に収容されており、且つ体温により膨張する膨
張体が充填されている伸縮性の加圧体を有し、装着後の
体温による加圧体の膨張により前記薬剤を生体方向に加
圧することができる経皮投与システム。
(57) [Claims] A medicine, a medicine holding body for holding the medicine, and a stretchable pressurized body that is housed in the medicine holding body and is filled with an inflatable body that expands due to body temperature. A transdermal administration system capable of pressurizing the medicine in the body direction by expanding a pressure body.
JP61140238A 1986-06-18 1986-06-18 Transdermal medication system Expired - Lifetime JP2757984B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61140238A JP2757984B2 (en) 1986-06-18 1986-06-18 Transdermal medication system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61140238A JP2757984B2 (en) 1986-06-18 1986-06-18 Transdermal medication system

Publications (2)

Publication Number Publication Date
JPS62298375A JPS62298375A (en) 1987-12-25
JP2757984B2 true JP2757984B2 (en) 1998-05-25

Family

ID=15264121

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61140238A Expired - Lifetime JP2757984B2 (en) 1986-06-18 1986-06-18 Transdermal medication system

Country Status (1)

Country Link
JP (1) JP2757984B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858112B2 (en) 2002-02-28 2010-12-28 Lintec Corporation Percutaneous absorption system and percutaneous absorption method
JP4608187B2 (en) * 2002-02-28 2011-01-05 リンテック株式会社 Transdermal preparation
JP2008125577A (en) * 2006-11-17 2008-06-05 Eisuke Imanaga Medicinal component delivery system, cup for operation and composition containing medicinal component
MX2009010524A (en) * 2007-03-29 2010-03-18 Cupola Medical Ltd Device and system for skin treatment.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534140B1 (en) * 1982-10-12 1986-01-31 Fournier Laboratoires NEW DEVICE FOR PERCUTANEOUS ADMINISTRATION OF MEDICINES
JPS59155267A (en) * 1983-02-23 1984-09-04 帝国製薬株式会社 Capsule pad adhering agent for subcateneous absorption

Also Published As

Publication number Publication date
JPS62298375A (en) 1987-12-25

Similar Documents

Publication Publication Date Title
EP1301236B1 (en) Delivery device with microneedles for the transdermal administration of a substance
EP1289588B1 (en) Apparatus for enhancing penetration of a puncturing member into the intradermal space
JP6402714B2 (en) Microneedle unit
EP0680766B1 (en) Transdermal perfusion of fluids
US7440798B2 (en) Substance delivery system
US6908448B2 (en) Substance delivery device
US4573996A (en) Device for the administration of an active agent to the skin or mucosa
JP4312407B2 (en) Skin treatment device for sustained transdermal drug delivery
JP2538371B2 (en) Medical device for transdermal or mucus administration of active substances
US7211062B2 (en) Solid solution perforator for drug delivery and other applications
EP1534376B1 (en) Rapidly dissolving micro-perforator for drug delivery and other applications
US5234690A (en) Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
AU2467788A (en) Device for administering an active agent to the skin or mucosa
JPWO2007091608A1 (en) Transdermal drug administration device with microneedle
KR950007808A (en) Medical device for drug administration
ES2044206T3 (en) PROCEDURE FOR OBTAINING A TRANSDERMAL THERAPEUTIC SYSTEM IN THE FORM OF A PLASTER WITH SEVERAL LAYERS.
JP2006149818A (en) Transdermal device
JP2757984B2 (en) Transdermal medication system
WO2007007128A1 (en) Apparatus for administrating substances into a body
JP4439793B2 (en) Infusion system
JPH031452Y2 (en)

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term